Suwanboriboon Wipawee, Chaiyapuk Thanaporn, Tinnabut Intraparch, Sanpawitayakul Gornmigar, Srisawat Chatchawan, Junnu Sarawut, Liammongkolkul Sompong, Chotipanang Kwanjai, Rukprayoon Hathaichanok, Laohathai Phakwan, Densupsoontorn Narumon
Division of Nutrition, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Division of Nephrology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Pediatr Nephrol. 2025 Jun 23. doi: 10.1007/s00467-025-06847-6.
Patients with chronic kidney disease (CKD) stage 5D receiving peritoneal dialysis (PD) are at risk for thiamin deficiency (TD). This study compared the proportion of TD in pediatric CKD patients undergoing PD with that in healthy controls and evaluated the associations of various factors with TD in CKD patients.
Thirty-two patients with CKD stage 5D and 34 healthy children were recruited. The participants reported their consumption of foods containing antithiamin factors and completed a 3-day food record to assess their intake of thiamin, energy, and macronutrients. The medical records of the CKD group were reviewed. Thiamin status was assessed via an erythrocyte transketolase activity assay, where the thiamin pyrophosphate effect was determined.
Thirteen percent of participants in the CKD group had TD, whereas 29% of the healthy controls did (p = 0.093). The CKD group had significantly greater total thiamin intake per 1,000 kcal of energy due to thiamin supplementation (2.14 [1.83, 2.99] vs. 0.87 [0.59, 1.14] mg/1,000 kcal; p < 0.001), despite inadequate dietary thiamin intake. A longer PD duration (in months) and a high-transport peritoneal membrane status were significantly associated with poorer thiamin status (β = + 0.59, p < 0.001, and β = + 0.38, p = 0.013, respectively). In contrast, greater total thiamin intake was correlated with improved thiamin status (β = -0.35, p = 0.022).
Thiamin deficiency was observed in 13% of pediatric CKD patients on PD and 29% of healthy controls. In CKD patients, TD was associated with longer PD duration (in months), high-transport peritoneal membrane status, and low total thiamin intake.
接受腹膜透析(PD)的5D期慢性肾脏病(CKD)患者存在硫胺素缺乏(TD)风险。本研究比较了接受PD的儿童CKD患者与健康对照者中TD的比例,并评估了CKD患者中各种因素与TD的相关性。
招募了32例5D期CKD患者和34名健康儿童。参与者报告了他们含有抗硫胺素因子食物的摄入量,并完成了一份为期3天的饮食记录,以评估他们硫胺素、能量和常量营养素的摄入量。对CKD组的病历进行了回顾。通过红细胞转酮醇酶活性测定评估硫胺素状态,测定硫胺素焦磷酸效应。
CKD组13%的参与者存在TD,而健康对照组为29%(p = 0.093)。尽管饮食中硫胺素摄入不足,但由于补充硫胺素,CKD组每1000千卡能量的总硫胺素摄入量显著更高(2.14 [1.83, 2.99] 与0.87 [0.59, 1.14] 毫克/1000千卡;p < 0.001)。较长的PD持续时间(以月为单位)和高转运腹膜状态与较差的硫胺素状态显著相关(β = +0.59,p < 0.001,以及β = +0.38,p = 0.013)。相反,较高的总硫胺素摄入量与改善的硫胺素状态相关(β = -0.35,p = 0.022)。
在接受PD的儿童CKD患者中观察到13%存在硫胺素缺乏,健康对照组为29%。在CKD患者中,TD与较长的PD持续时间(以月为单位)、高转运腹膜状态和较低的总硫胺素摄入量相关。